Christopher McNamara
Overview
Explore the profile of Christopher McNamara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhary C, Kloczko E, Spencer A, McNamara C, Gohil S, Semkova K, et al.
Clin Exp Dermatol
. 2024 Aug;
50(1):214-216.
PMID: 39141881
No abstract available.
2.
Carroll A, Doherty C, Blake J, Hunt S, Hoskote C, McNicholl F, et al.
Pract Neurol
. 2022 May;
PMID: 35534197
The histiocytoses are a group of rare disorders characterised by the accumulation of neoplastic or non-neoplastic activated histiocytes in various tissues. Phenotypes vary widely from cutaneous lesions or lymphadenopathy that...
3.
Hagos Y, Akarca A, Ramsay A, Rossi R, Pomplun S, Ngai V, et al.
Hematol Oncol
. 2022 Apr;
40(4):541-553.
PMID: 35451108
The spatial architecture of the lymphoid tissue in follicular lymphoma (FL) presents unique challenges to studying its immune microenvironment. We investigated the spatial interplay of T cells, macrophages, myeloid cells...
4.
Linden O, Bates A, Cunningham D, Hindorf C, Larsson E, Cleton A, et al.
Cancer Biother Radiopharm
. 2021 Apr;
36(8):672-681.
PMID: 33887152
BAY 1862864 is an α-particle emitting Th-labeled CD22-targeting antibody. This first-in-human dose-escalation phase I study evaluated BAY 1862864 in patients with CD22-positive relapsed/refractory B cell non-Hodgkin lymphoma (R/R-NHL). BAY 1862864...
5.
Yim Y, Wallis G, Saeed J, Voo S, Kayani I, Amin Z, et al.
Br J Haematol
. 2021 Mar;
193(2):e15-e18.
PMID: 33713417
No abstract available.
6.
Burns D, Clesham K, Hodgson Y, Fredrick L, Haughton J, Lannon M, et al.
Transplantation
. 2020 Oct;
104(12):2582-2590.
PMID: 33104308
Background: Optimal upfront therapy for posttransplant lymphoproliferative disease (PTLD) arising after solid organ transplant remains contentious. Rituximab monotherapy (R-Mono) in unselected patients has shown a lack of durable remissions. Cyclophosphamide,...
7.
Bauchmuller K, Manson J, Tattersall R, Brown M, McNamara C, Singer M, et al.
J Intensive Care Soc
. 2020 Aug;
21(3):256-268.
PMID: 32782466
Haemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe immune dysregulation, characterised by extreme inflammation, fever, cytopaenias and organ dysfunction. HLH can be triggered by conditions such as infection, autoimmune disease...
8.
McNamara C, Montoto S, Eyre T, Ardeshna K, Burton C, Illidge T, et al.
Br J Haematol
. 2020 Jun;
191(3):363-381.
PMID: 32579717
No abstract available.
9.
Thomas D, Oken E, Rifas-Shiman S, Tellez-Rojo M, Just A, Svensson K, et al.
Obesity (Silver Spring)
. 2019 Jun;
27(7):1161-1167.
PMID: 31149770
Objective: Prepregnancy weight may not always be known to women. A model was developed to estimate prepregnancy weight from measured pregnancy weight. Methods: The model was developed and validated using...
10.
Chen L, Shah R, Cwynarski K, Lambert J, McNamara C, Mohamedbhai S, et al.
Br J Haematol
. 2018 Jan;
184(3):462-465.
PMID: 29363752
No abstract available.